GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. Logo

GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş.

A travel agency offering online booking for transport, hotels, cultural tours, and cruises.

GZNMI | IS

Overview

Corporate Details

ISIN(s):
TREGZNM00019 (+1 more)
LEI:
789000AQ1MOIA4NL0454
Country:
Türkiye
Address:
MEHMETÇİK MAH. 1242 SK. NO:3B / 2 MURATPAŞA, 07300 ANTALYA
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Gezinomi Seyahat Turizm Ticaret A.Ş. is a tour operator and travel agency established in 2011. The company's core business involves providing comprehensive travel arrangement and reservation services. Its offerings include ticket sales for air, sea, land, and rail transportation, as well as domestic and international hotel accommodations, cultural tours, and cruise packages. Operating through its website and mobile application, Gezinomi provides a digital platform for customers to plan and book their holidays. The company completed a successful Initial Public Offering in March 2022.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 08:04
Major Shareholding Notification
Company General Info Form
English 1.9 KB
2025-10-02 07:58
Regulatory News Service
Bizzcar Yeni Araç Yatırımı Hakkında
Turkish 17.2 KB
2025-09-12 17:08
Pre-Annual General Meeting Information
Olağanüstü Genel Kurul Toplantı Daveti
Turkish 209.4 KB
2025-09-12 17:08
Pre-Annual General Meeting Information
Olağanüstü Genel Kurul Toplantı Daveti
Turkish 306.3 KB
2025-09-12 17:08
Pre-Annual General Meeting Information
Olağanüstü Genel Kurul Toplantı Daveti
Turkish 10.2 KB
2025-09-10 16:48
Regulatory News Service
SPK başvurusunun yapılması Hk.
Turkish 6.0 KB
2025-09-09 18:46
Capital/Financing Update
İhraç Tavanına İlişkin Bildirim
Turkish 5.7 KB
2025-09-08 17:34
Registration Form
Company General Info Form
English 13.4 KB
2025-08-21 14:10
Regulatory News Service
İstanbul Deniz Otobüsleri (İDO) ile yapılan iş birliği anlaşması Hk.
Turkish 19.4 KB
2025-08-20 18:24
Share Issue/Capital Change
Bağlı Ortaklık Sermaye Artırımı Hakkında
Turkish 17.8 KB
2025-08-19 17:33
Regulatory News Service
Participation Finance Principles Information Form
Turkish 52.6 KB
2025-08-19 17:33
Regulatory News Service
Sorumluluk Beyanı
Turkish 20.6 KB
2025-08-19 17:32
Management Discussion and Analysis
30.06.2025 Gezinomi Konsolide Faaliyet Raporu
Turkish 788.6 KB
2025-08-19 17:32
Regulatory News Service
30.06.2025 Gezinomi Konsolide Faaliyet Raporu
Turkish 11.1 KB
2025-08-19 17:32
Interim Report
Financial Report
Turkish 1.2 MB

Automate Your Workflow. Get a real-time feed of all GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.